报告时间：2023年5月22日下午2点

报告地点：2教南228会议室

报告题目：

Biomedical engineering to develop new therapeutic approaches in demyelinating diseases

摘要：

Within the Department of Basic and Biomedical Sciences of the Université Paris Cité, we have a unique multidisciplinary environment to develop innovative therapeutic and technological approaches for health. We have brought together on the same site complementary expertises in biochemical synthesis, molecular and cellular biology, pharmacotoxicology, metabolomic, biophysics and neuroscience (from the molecule to the human).

To complete this ecosystem and promote education and bio-entrepreneurship, we have created an international graduate school in BioMedical Engineering that gathers students, researchers, startups and companies working in this field.

I will illustrate the contribution of biomedical engineering by presenting two recent innovations realized in our team: a myelin-on-a-chip platform and biogenic delivery systems applied to demyelinating pathologies.

教授信息：

Professor Sophie Bernard

Sophie Bernard is Professor of Physics at the Faculty of Basic and Biomedical Sciences of Paris Descartes University.

Her current research is focused on the real-time ****ysis of the process of myelination, the quantification of the cytoskeleton remodeling and Wnt signaling.

She passed a B.Sc. in fundamental physics and a PhD in biophysics in 1996 at Paris 7Diderot University on the development of Surface Enhanced Raman Scatteringto follow anti-tumor drugs in cancer cells and to characterize their adducts with nucleic acids. She conducted postdoctoral research at the Pasteur Institute (Paris) in partnership with Pfizer research group (Connecticut, USA) and joined in 1999 the Paris Descartes University where she passed her Habilitation in 2006.